Profile data is unavailable for this security.
About the company
Kyowa Kirin Co., Ltd., formerly Kyowa Hakko Kirin Co., Ltd. is a Japan-based company principally engaged in the manufacture and sale of medical drugs. The Company operates through two business segments. Pharmaceuticals segment conducts research, development, manufacture and sale of pharmaceuticals and other products. Bio-chemicals segment is involved in the research, development, manufacture and sale of pharmaceuticals and industrial raw materials mainly for amino acid and nucleic acid related substances, as well as healthcare products.
- Revenue in JPY (TTM)325.55bn
- Net income in JPY44.30bn
- Incorporated1949
- Employees5.42k
- LocationKyowa Kirin Co LtdOtemachi Financial City Grand Cube1-9-2, Ote-machiCHIYODA-KU 100-0004JapanJPN
- Phone+81 352057200
- Fax+81 352057182
- Websitehttps://www.kyowakirin.co.jp/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Peptidream Inc | 11.45bn | 4.33bn | 497.94bn | 128.00 | 115.00 | 22.45 | 101.27 | 43.49 | 33.30 | 33.30 | 88.90 | 170.59 | 0.5201 | 3.78 | 13.18 | 89,445,060.00 | 19.66 | -- | 21.52 | -- | 80.85 | -- | 37.81 | -- | 6.70 | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- |
| Medipal Holdings Corp | 3.24tn | 26.47bn | 549.94bn | 12.97k | 19.03 | 0.8933 | 10.76 | 0.1696 | 118.18 | 118.18 | 14,532.31 | 2,517.51 | 1.93 | 20.26 | 4.57 | 249,929,700.00 | 2.18 | 2.63 | 5.96 | 7.42 | 6.63 | 7.13 | 1.13 | 1.33 | 1.07 | -- | 0.0449 | 25.33 | -1.29 | 1.18 | -36.98 | -4.91 | -16.41 | 8.45 |
| Santen Pharmaceutical Co Ltd | 257.03bn | 8.02bn | 671.82bn | 4.23k | 84.01 | 2.15 | 27.59 | 2.61 | 19.97 | 19.97 | 642.22 | 779.36 | 0.6373 | 2.53 | 2.92 | 60,777,490.00 | 1.96 | 6.09 | 2.33 | 7.32 | 60.94 | 61.26 | 3.07 | 10.21 | 2.29 | 17.48 | 0.0959 | 44.96 | 3.33 | 5.03 | -71.10 | -33.72 | 21.23 | 2.29 |
| Nippon Shinyaku Co., Ltd. | 133.13bn | 27.21bn | 675.12bn | 2.06k | 23.79 | 3.80 | 22.04 | 5.07 | 403.96 | 403.96 | 1,976.59 | 2,526.54 | 0.7035 | 1.49 | 3.19 | 64,657,120.00 | 14.39 | 9.63 | 16.67 | 11.41 | 62.17 | 55.58 | 20.45 | 14.21 | 4.04 | -- | 0.00 | 30.43 | 4.50 | 7.68 | 22.74 | 26.70 | 4.93 | 28.73 |
| Sumitomo Dainippon Pharma Co Ltd | 513.29bn | 42.76bn | 827.63bn | 6.82k | 19.32 | 1.44 | 17.03 | 1.61 | 107.63 | 107.63 | 1,291.97 | 1,444.88 | 0.4085 | 1.61 | 3.51 | 75,240,540.00 | 1.76 | 4.40 | 2.73 | 6.47 | 72.67 | 74.83 | 4.30 | 8.84 | 1.35 | -- | 0.2996 | 22.77 | 6.88 | 5.05 | 37.95 | 17.88 | 2.10 | 9.24 |
| ONO PHARMACEUTICAL CO., LTD. | 321.73bn | 78.00bn | 1.42tn | 3.61k | 17.24 | 2.09 | 15.09 | 4.42 | 156.25 | 156.25 | 644.47 | 1,291.15 | 0.4527 | 2.37 | 3.80 | 89,197,120.00 | 10.99 | 9.18 | 12.46 | 10.58 | 72.71 | 72.84 | 24.27 | 21.01 | 2.53 | -- | 0.0134 | 39.25 | 5.77 | 14.05 | 26.33 | 24.73 | 7.58 | 6.79 |
| Kyowa Kirin Co Ltd | 325.55bn | 44.30bn | 2.20tn | 5.42k | 49.50 | 3.04 | 33.99 | 6.77 | 82.42 | 82.42 | 605.69 | 1,341.00 | 0.4071 | 1.52 | 3.66 | 60,032,080.00 | 5.54 | 5.63 | 6.12 | 6.35 | 75.20 | 68.95 | 13.61 | 12.98 | 5.22 | -- | 0.0252 | 45.26 | 4.10 | -2.66 | 24.83 | 9.57 | 11.88 | 11.97 |
| Eisai Co., Ltd | 679.25bn | 59.86bn | 2.47tn | 11.24k | 39.96 | 3.31 | 25.48 | 3.64 | 208.78 | 208.78 | 2,369.30 | 2,519.88 | 0.6261 | 2.02 | 3.23 | 60,447,900.00 | 5.53 | 6.26 | 7.45 | 8.36 | 76.11 | 70.87 | 8.84 | 10.50 | 1.70 | -- | 0.1103 | 69.26 | -7.14 | 3.35 | -65.41 | -5.17 | -0.9813 | 1.30 |
| Daiichi Sankyo Co Ltd | 989.64bn | 79.32bn | 5.39tn | 16.03k | 67.50 | 4.15 | 39.30 | 5.45 | 41.02 | 41.02 | 511.55 | 667.96 | 0.4798 | 1.73 | 3.94 | 61,725,000.00 | 3.84 | 4.03 | 4.54 | 4.90 | 65.52 | 63.64 | 8.01 | 8.41 | 3.07 | -- | 0.1255 | 57.46 | -1.96 | -0.49 | -41.34 | -1.63 | -1.58 | 6.19 |
Data as of Sep 17 2021. Currency figures normalised to Kyowa Kirin Co Ltd's reporting currency: Japanese Yen JPY
12.05%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Nomura Asset Management Co., Ltd.as of 31 Aug 2021 | 19.82m | 3.67% |
| Nikko Asset Management Co., Ltd.as of 02 Sep 2021 | 8.87m | 1.64% |
| Massachusetts Financial Services Co.as of 30 Jul 2021 | 7.76m | 1.44% |
| The Vanguard Group, Inc.as of 03 Sep 2021 | 6.22m | 1.15% |
| BlackRock Fund Advisorsas of 02 Sep 2021 | 4.71m | 0.87% |
| Mitsubishi UFJ Kokusai Asset Management Co., Ltd.as of 02 Sep 2021 | 4.59m | 0.85% |
| Daiwa Asset Management Co. Ltd.as of 31 Aug 2021 | 4.04m | 0.75% |
| Norges Bank Investment Managementas of 31 Dec 2020 | 3.95m | 0.73% |
| JPMorgan Asset Management (UK) Ltd.as of 02 Sep 2021 | 3.20m | 0.59% |
| Sumitomo Mitsui DS Asset Management Co., Ltd.as of 10 Sep 2021 | 1.94m | 0.36% |
More ▼
Data from 31 Dec 2020 - 30 Jun 2021Source: FactSet Research Systems Inc.
